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BACKGROUND: 
Heart disease is the leading cause of death in both men and women, accounting for 
nearly one-fourth of the deaths in the USA in 2010 [1].  Coronary heart disease 
(CHD) is the most common type of heart disease with about 715,000 heart attacks 
occurring in the United States each year.  Startlingly, nearly 75% of these heart 
attacks are in those without known coronary disease [2].  Thus, primary 
prevention of CHD is often the responsibility of primary care physicians in the 
outpatient setting. In 2001, the Adult Treatment Panel III (ATPIII) published clinical 
guidelines to aid in the primary prevention of CHD [3].  A critical component of 
these guidelines is the use of the Framingham Risk Score (FRS) to guide treatment. 
Recent data have shown that improving cholesterol primarily through reductions in 
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LDL reduces CHD mortality [4]. Aspirin has also shown similar benefits in primary prevention [5]. 
We observed that the primary prevention of CHD in the outpatient internal medicine resident 
clinic at the University of Missouri Healthcare System (UMHC) was compromised by inadequate 
documentation of CHD risk factors and FRS. Further, we hypothesized that increasing the 
documentation of FRS would improve management of CHD and thereby prevent future coronary 
events.  
 
AIM: 
To increase the documentation of the 10-year Framingham Hard CHD Risk Score for patients in 
the outpatient internal medicine resident clinic at UMHC from 3% in December 2011 to 50% by 
December 2012. 
 
METHODS: 
Following approval from the UMHC institutional review board, we performed baseline data 
collection through a chart review of 60 random patients from the outpatient internal medicine 
resident clinic at UMHC.  Charts were reviewed for documentation of CHD risk factors and FRS in 
the preceding twelve months.  Patients without CHD or CHD risk equivalents, according to ATPIII, 
were categorized as primary prevention and all others were categorized as secondary prevention.  
We then reviewed for the percentage of patients undergoing lipid monitoring and percentage with 
LDL at goal, again according to ATPIII guidelines. We also examined for aspirin prophylaxis 
according to the US Preventative Services Task Force (USPSTF) guidelines. We compared the 
incidence of these endpoints between the primary prevention and secondary prevention groups. 
We then identified stakeholders utilizing fishbone diagramming and developed interventions utilizing 
effort/yield study [6]. Based on these studies, we implemented a multi-faceted intervention to 
increase the documentation of FRS [6]. We placed ATPIII Quick Desk Reference handouts at each 
physician cubicle in the resident clinic and performed serial educational seminars for all internal 
medicine resident physicians on appropriate use of ATPIII guidelines and documentation of FRS and 
treatments. Four months after our intervention, we conducted follow-up data collection on 60 
random patients in an identical manner as our baseline data collection. After follow-up data 
collection, we compared incidences between the pre- and post-intervention primary prevention 
groups. Data for each endpoint were presented as percentage of patients from each group positive 
for variable in question.  Statistical analyses of our baseline and follow-up data collections were 
done using chi-square test with p value <0.05 considered significant.  
 
RESULTS: 
Our baseline data collection revealed that only 3% of primary prevention patients had 
documentation of their FRS and only 18% of patients had their CHD risk factors documented.  
Further baseline data analysis revealed that primary prevention patients were significantly less likely 
than secondary prevention patients to have lipid monitoring performed, 59% versus 83% 
respectively. Additionally, the primary prevention group had significantly fewer patients with LDL at 
goal, 61% compared to 77% respectively. Finally, primary prevention patients were significantly less 
likely to be on appropriate aspirin prophylaxis with only 55% of the primary prevention group on 
appropriate aspirin prophylaxis compared to 87% of the secondary prevention group.  
 
After our intervention, we found significant improvement in the documentation of FRS with an 
increase from 3% at baseline to 34% of patient charts having FRS documentation (p value <0.001). 
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Documentation of CHD risk factors also showed an increased trend from 18% to 37% but this 
difference did not achieve statistical significance (p value 0.07). Importantly, the percentage of 
primary prevention patients who underwent lipid monitoring increased significantly from 59% to 
90% (p value <0.001). Percentage of patients with LDL at goal increased to 78% and appropriate 
aspirin prophylaxis increased to 76% but neither result achieved statistical significance.  
 
CONCLUSIONS: 
A quality improvement process to improve the primary prevention of CHD at the UMHC 
outpatient internal medicine resident clinic achieved a significant increase in FRS documentation 
through resident education and quick reference postings.  This improvement significantly increased 
incidence of lipid monitoring and showed a trend towards increasing the percentage of patients with 
LDL at goal and on appropriate aspirin prophylaxis. Repeated cycles of quality improvement and 
hard changes to the electronic medical record are needed to achieve the stated goal of FRS 
documentation and significantly increase the adherence to ATPIII and USPSTF guidelines for CHD 
prevention. 
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Case Report 
 
65-year-old male patient with left sided headache and orbital pain of 2-3 months 
duration 
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Introduction: 
Despite advancement of neurotechnology and neuroimaging, detailed history and examination 
remain the most important tools for diagnosis of unilateral headache and orbital pain. Headache is a 
common symptom among all age groups with a considerable array of differential diagnoses. Tolosa 
